Skip to main content
Log in

Tenosynovialer Riesenzelltumor

Morphologische, ultrastrukturelle und immunhistochemische Befunde sowie Differenzialdiagnose riesenzellhaltiger Tumoren des Weichgewebes

Tenosynovial giant cell tumor

  • Schwerpunkt: Weichgewebstumoren
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Die morphologischen, ultrastrukturellen und immunhistochemischen Befunde an 12 tenosynovialen Riesenzelltumoren (TSRZT) der diffusen Form/pigmentierte villonoduläre Synovialitis (PVNS) wurden im Vergleich zur Morphologie von 30 Tumoren der lokalisierten Form (Riesenzelltumoren der Sehnenscheide) erstellt sowie im Hinblick auf die formale Pathogenese, Abgrenzung der beiden Varianten und Differenzialdiagnose diskutiert.

Die diffuse Form des TSRZT/PVNS ist charakterisiert durch ein auffallendes Vaskularisationsmuster mit teils abnormem Strukturmuster (lückenhafte Endothel-, Perizytenanordnungen). Die Tumorproliferate des TSRZT führen offenbar zu stärkeren Kompressionsphänomenen der Gefäße, sodass zusammen mit der sehr ausgeprägten Vaskularisation bei ultrastrukturell nachweisbaren teils „fragilen“ Gefäßwandstrukturen eine vermehrte Einblutung des Gewebes mit Hämosiderose und Ansammlung mehrkerniger (Osteoklasten-artiger) Riesenzellen gefördert wird. Mikrohämorrhagiefoci mit nahezu immer angrenzenden mehrkernigen Riesenzellen waren in 83% der diffusen Tumoren sowie in 67% der lokalisierten Tumoren zu belegen. Neben den dünnwandigen ektatischen, teilweise dicht gelagerten Gefäßstrukturen waren als typische morphologische Befunde des diffusen TSRZT „Riesenhämosideringranula“, meist zahlreiche „Ringsiderophagen“ sowie pseudoalveoläre Spalträume und irregulär anastomosierende Synovialiszotten nachzuweisen. Weder die mitotische Aktivität, die Anzahl der Riesenzellen noch die Kernanzahl der Riesenzellen (als Maß für die Zellgröße) zeigten statistisch signifikante Unterschiede zwischen lokalisierter und diffuser Form des TSRZT. Immunhistochemisch fand sich in der diffusen Variante neben CD68 fokal eine Expression von CD31 (in 75%) und Calretinin (in 63%).

Abstract

Morphological, ultrastructural, and immunohistochemical findings of 12 diffuse type-tenosynovial giant cell tumors/pigmented villonodular synovitis are presented compared to 30 localized tenosynovial giant cell tumors (giant cell tumor of tendon sheath).

Diffuse-type-tenosynovial giant cell tumor is characterized by a striking vascularisation pattern composed of densely arranged thin-walled, partly slit-like and partly hyalinized small blood vessels within the papillary synovial fronds. These vessels may show abnormal structures with incompletely arranged endothelial cells/pericytes. The fibrohistiocytic tumor cells probably cause considerable compression/distortion or destruction of the small vessels which might be responsible for an increased blood deposition and massive hemosiderosis. Accompanying multinucleated osteoclast-like giant cells seemingly are recruited from circulating blood monocytes. Microhemorrhagic foci with multinucleated giant cells could be detected in 83% of diffuse-type and 67% of localized-type tumors. Apart from the described vessels, typical morphological findings in diffuse-type tenosynovial giant cell tumors included “giant” hemosiderotic granules, (at least 2–3 times the diameter of an erythrocyte) “giant” siderophages, pseudoalveolar clefts and irregularly anastomosing synovial fronds. Neither mitotic rate nor the amount of giant cells/amount of nuclei of giant cells revealed statistically significant differences between localized-type and diffuse-type of tenosynovial giant cell tumor. Immunohistochemically, the diffuse-type exhibited focal expression of CD31 (in 75% of tumors) and calretinin (in 63%) besides CD68-staining.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Abdul-Karim FA, El-Naggar AK, Joyce MJ et al. (1992) Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol 23:729–735

    Article  CAS  PubMed  Google Scholar 

  2. Alguacil-Garcia A, Unni KK, Goellner JR (1978) Giant cell tumor of tendon sheath and pigmented villonodular synovitis: an ultrastructural study. Am J Clin Pathol 69:6–17

    Google Scholar 

  3. Benthien JP, Werner M, Delling G, Rüther W (2003) Die pigmentierte villonoduläre Synovialitis des Hüftgelenkes: Diagnostik und Therapie einer invasiven Erkrankung. Z Rheumatol 62:185–189

    Article  Google Scholar 

  4. Bertoni F, Unni KK, Beabout JW, Sim FH (1997) Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol 21:153–163

    Article  Google Scholar 

  5. Fletcher JA, Henkle C, Atkins L et al. (1992) Trisomy 5 and trisomy 7 are non-random aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells. Genes Chromosomes Cancer 4:264–266

    Google Scholar 

  6. Folpe AL, Weiss SW, Fletcher CDM, Gown AM (1998) Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation. Mod Pathol 11:939–944

    Google Scholar 

  7. Jaffe HL, Lichtenstein L, Sufro CJ (1941) Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol 31:731–765

    Google Scholar 

  8. Layfield LL, Meloni-Ehrig A, Liu K et al. (2000) Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis): a histopathologic and fluorescence in situ hybridization analysis of 2 cases with review of the literature. Arch Pathol Lab Med 124:1636–1641

    Google Scholar 

  9. McKenney JK, Weiss SW, Folpe Al (2001) CD 31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol 25:1167–1173

    Article  Google Scholar 

  10. Mentzel T, Calonje E, Fletcher CDM (1994) Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma. Am J Surg Pathol 18:258–265

    Google Scholar 

  11. Mertens FM, Örndal C, Mandahl N et al. (1993) Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue. Genes Chromosomes Cancer 6:212–217

    Google Scholar 

  12. Mitelman Database of Chromosome Abberations in Cancer (2002) http://cgap nci nhi gov/Chromosomes/Mitelman

  13. Mohr W (1992) Pigmentierte villonoduläre Synovitis—eine Übersicht unter Berücksichtigung von 166 Beobachtungen. Pathologe 13:314–321

    CAS  PubMed  Google Scholar 

  14. Nielsen AL, Kiaer T (1989) Malignant giant cell tumor of synovium and locally destructive pigmented villonodular synovitis: ultrastructural and immunohistochemical study and review of the literature. Hum Pathol 20:765–771

    Article  CAS  PubMed  Google Scholar 

  15. O’Connell JX, Fanburg JC, Rosenberg AE (1995) Giant cell tumor of tendon sheath and pigmented villonodular synovitis: immunophenotype suggests a synovial cell origin. Hum Pathol 26:771–775

    Article  Google Scholar 

  16. Oehler S, Fassbender HG, Neureiter D et al. (2000) Cell population involved in pigmented villonodular synovitis of the knee. J Rheumatol 27:463–470

    Google Scholar 

  17. Oliveira AM, Dei Tos AP, Fletcher CDM, Nascimento AG (2000) Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol 24:248–256

    Article  Google Scholar 

  18. Rowlands CG, Roland B, Hwang WS, Sevick RJ (1994) Diffuse-variant tenosynovial giant cell tumor: a rare and aggressive lesion. Hum Pathol 25:423–425

    Article  Google Scholar 

  19. Sakkers RJB, de Jong D, van der Heul RO (1991) X-chromosome inactivation in patients who have pigmented villonodular synovitis. J Bone Joint Surg 73:1532–1536

    Google Scholar 

  20. Sciot R, Rosai J, Dal Cin P et al. (1999) Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the chromosomes and morphology (CHAMP) study group. Mod Pathol 12:576–579

    CAS  PubMed  Google Scholar 

  21. Scott PM (1968) Bone lesions in pigmented villonodular synovitis. J Bone Joint Surg Br 50: 306–311

    Google Scholar 

  22. Somerhausen NS, Dal Cin P (2002) Diffuse-type giant cell tumor. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 112–114

  23. Somerhausen NS, Fletcher CDM (2000) Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol 24:479–492

    Article  Google Scholar 

  24. Vogrincic GS, O‚Connell JX, Gilks B (1997) Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol 28:815–819

    Article  Google Scholar 

  25. Weiss SW, Goldblum JR (2001) Benign tumors and tumor-like lesions of synovial tissue. In: Enzinger and Weiss’s Soft Tissue Tumours, 4th edn. Mosby Harcourt, Philadelphia, pp 1037–1062

Download references

Danksagung

Die Autoren danken Frau Cornelia Troske für das Fotodesign.

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Kuhnen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuhnen, C., Müller, KM., Rabstein, S. et al. Tenosynovialer Riesenzelltumor. Pathologe 26, 96–110 (2005). https://doi.org/10.1007/s00292-004-0740-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-004-0740-3

Schlüsselwörter

Keywords

Navigation